- Home
- RCUS vs UUUU Comparison
RCUS vs UUUU Comparison
Compare RCUS & UUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- UUUU
- Stock Information
- Founded
- RCUS 2015
- UUUU 1987
- Country
- RCUS United States
- UUUU United States
- Employees
- RCUS N/A
- UUUU N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- RCUS Health Care
- UUUU Industrials
- Exchange
- RCUS Nasdaq
- UUUU Nasdaq
- Market Cap
- RCUS 727.1M
- UUUU 613.7M
- IPO Year
- RCUS 2018
- UUUU N/A
- Fundamental
- Price
- RCUS $7.88
- UUUU $4.95
- Analyst Decision
- RCUS Strong Buy
- UUUU Strong Buy
- Analyst Count
- RCUS 10
- UUUU 3
- Target Price
- RCUS $29.50
- UUUU $8.42
- AVG Volume (30 Days)
- RCUS 1.2M
- UUUU 8.3M
- Earning Date
- RCUS 05-07-2025
- UUUU 05-02-2025
- Dividend Yield
- RCUS N/A
- UUUU N/A
- EPS Growth
- RCUS N/A
- UUUU N/A
- EPS
- RCUS N/A
- UUUU N/A
- Revenue
- RCUS $258,000,000.00
- UUUU $78,114,000.00
- Revenue This Year
- RCUS N/A
- UUUU $13.82
- Revenue Next Year
- RCUS $25.77
- UUUU $213.99
- P/E Ratio
- RCUS N/A
- UUUU N/A
- Revenue Growth
- RCUS 120.51
- UUUU 105.95
- 52 Week Low
- RCUS $6.50
- UUUU $3.20
- 52 Week High
- RCUS $18.98
- UUUU $7.47
- Technical
- Relative Strength Index (RSI)
- RCUS 44.26
- UUUU 69.34
- Support Level
- RCUS $6.75
- UUUU $4.06
- Resistance Level
- RCUS $8.36
- UUUU $3.87
- Average True Range (ATR)
- RCUS 0.60
- UUUU 0.32
- MACD
- RCUS 0.16
- UUUU 0.15
- Stochastic Oscillator
- RCUS 74.19
- UUUU 91.15
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. Its producing White Mesa Mill is the only conventional uranium mill in the United States and has a licensed capacity of approximately 8 million pounds of U3O8 per year. Nichols Ranch is in production and has a licensed capacity of approximately 2 million pounds of U3O8 per year. It also produces vanadium. Energy Fuels also owns several licensed and developed uranium and vanadium mines on standby and other projects in development.